Quidel Stock Forecast, Price & News

-5.10 (-3.47 %)
(As of 09/16/2021 10:46 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume1,872 shs
Average Volume843,938 shs
Market Capitalization$5.91 billion
P/E Ratio6.88
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive QDEL News and Ratings via Email

Sign-up to receive the latest news and ratings for Quidel and its competitors with MarketBeat's FREE daily newsletter.

Quidel logo

About Quidel

Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value





Social Links


Overall MarketRank

2.17 out of 5 stars

Medical Sector

376th out of 1,352 stocks

Diagnostic Substances Industry

2nd out of 25 stocks

Analyst Opinion: 1.2Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 2.5Valuation: 2.5 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Quidel (NASDAQ:QDEL) Frequently Asked Questions

Is Quidel a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quidel in the last twelve months. There are currently 1 sell rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Quidel stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in QDEL, but not buy additional shares or sell existing shares.
View analyst ratings for Quidel
or view top-rated stocks.

What stocks does MarketBeat like better than Quidel?

Wall Street analysts have given Quidel a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Quidel wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Quidel's next earnings date?

Quidel is scheduled to release its next quarterly earnings announcement on Thursday, November 4th 2021.
View our earnings forecast for Quidel

How were Quidel's earnings last quarter?

Quidel Co. (NASDAQ:QDEL) announced its earnings results on Thursday, August, 5th. The company reported $0.64 earnings per share for the quarter, missing the consensus estimate of $1.06 by $0.42. The company earned $176.61 million during the quarter, compared to analyst estimates of $173.29 million. Quidel had a trailing twelve-month return on equity of 73.85% and a net margin of 48.96%.
View Quidel's earnings history

How has Quidel's stock been impacted by COVID-19?

Quidel's stock was trading at $89.68 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, QDEL shares have increased by 64.0% and is now trading at $147.11.
View which stocks have been most impacted by COVID-19

What price target have analysts set for QDEL?

3 Wall Street analysts have issued twelve-month price objectives for Quidel's shares. Their forecasts range from $80.00 to $219.00. On average, they anticipate Quidel's stock price to reach $148.50 in the next year. This suggests a possible upside of 0.9% from the stock's current price.
View analysts' price targets for Quidel
or view top-rated stocks among Wall Street analysts.

Who are Quidel's key executives?

Quidel's management team includes the following people:
  • Douglas C. Bryant, President, Chief Executive Officer & Director
  • Robert Joseph Bujarski, Chief Operating Officer
  • Randall J. Steward, Chief Financial & Accounting Officer
  • Werner Kroll, Senior Vice President-Research & Development
  • Karen C. Gibson, SVP-Information Systems & Business Transformation

What is Doug Bryant's approval rating as Quidel's CEO?

47 employees have rated Quidel CEO Doug Bryant on Doug Bryant has an approval rating of 76% among Quidel's employees.

Who are some of Quidel's key competitors?

What other stocks do shareholders of Quidel own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Quidel investors own include NVIDIA (NVDA), DocuSign (DOCU), Tesla (TSLA), PayPal (PYPL), Shopify (SHOP), Square (SQ), Teladoc Health (TDOC), Netflix (NFLX), Advanced Micro Devices (AMD) and Zoom Video Communications (ZM).

What is Quidel's stock symbol?

Quidel trades on the NASDAQ under the ticker symbol "QDEL."

Who are Quidel's major shareholders?

Quidel's stock is owned by a number of retail and institutional investors. Top institutional investors include Price T Rowe Associates Inc. MD (15.75%), Vanguard Group Inc. (9.28%), BlackRock Inc. (7.90%), Brown Capital Management LLC (6.35%), State Street Corp (2.50%) and ArrowMark Colorado Holdings LLC (2.05%). Company insiders that own Quidel stock include Charles P Slacik, Douglas C Bryant, Edward Keith Russell, Edward L Michael, Mary Lake Ph D Polan, Matthew Strobeck, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski, Werner Kroll and William J Ferenczy.
View institutional ownership trends for Quidel

Which institutional investors are selling Quidel stock?

QDEL stock was sold by a variety of institutional investors in the last quarter, including Thrivent Financial for Lutherans, Goldman Sachs Group Inc., AQR Capital Management LLC, BlackRock Inc., Oracle Investment Management Inc., Public Employees Retirement Association of Colorado, Assetmark Inc., and Wells Fargo & Company MN. Company insiders that have sold Quidel company stock in the last year include Charles P Slacik, Mary Lake Ph D Polan, Werner Kroll, and William J Ferenczy.
View insider buying and selling activity for Quidel
or view top insider-selling stocks.

Which institutional investors are buying Quidel stock?

QDEL stock was bought by a variety of institutional investors in the last quarter, including Brown Capital Management LLC, Massachusetts Financial Services Co. MA, JPMorgan Chase & Co., Senvest Management LLC, ArrowMark Colorado Holdings LLC, Price T Rowe Associates Inc. MD, Los Angeles Capital Management LLC, and Kempen Capital Management N.V.. Company insiders that have bought Quidel stock in the last two years include Douglas C Bryant, Edward L Michael, and Matthew Strobeck.
View insider buying and selling activity for Quidel
or or view top insider-buying stocks.

How do I buy shares of Quidel?

Shares of QDEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Quidel's stock price today?

One share of QDEL stock can currently be purchased for approximately $147.11.

How much money does Quidel make?

Quidel has a market capitalization of $6.12 billion and generates $1.66 billion in revenue each year. The company earns $810.29 million in net income (profit) each year or $19.55 on an earnings per share basis.

How many employees does Quidel have?

Quidel employs 1,370 workers across the globe.

When was Quidel founded?

Quidel was founded in 1979.

What is Quidel's official website?

The official website for Quidel is

Where are Quidel's headquarters?

Quidel is headquartered at 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA, 92121.

How can I contact Quidel?

Quidel's mailing address is 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA, 92121. The company can be reached via phone at (858) 552-1100 or via email at [email protected]

This page was last updated on 9/16/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.